KENNEDY ON FDA IDENTIFICATION OF HEPARIN CONTAMINANT
WASHINGTON, DC— Today, Senator Edward M. Kennedy, Chairman of the Health,
Education, Labor and Pensions Committee, released the following statement in response
to the FDA’s announcement that they have identified the contaminant in the blood
thinner heparin, a chemical compound called oversulfated chondroitin sulfate. Senator
Kennedy will be sending letters to the FDA and industry later today.
“It is unacceptable that Americans have died and been seriously injured by what appears
to be deliberate tampering. Whether this contaminant was introduced intentionally or by
accident, the full force of the law must be brought to bear to bring those responsible to
justice. To guard against future abuses, every drug manufacturer needs to inform FDA of
where it sources its ingredients and what it is doing to ensure that these ingredients are
pure and potent.”